Pub. Date : 2019 May 7
PMID : 30131091
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Moreover, an adenocarcinoma patient harboring concurrent RET fusion and EGFR L858R responded to combinatorial treatment of cabozantinib and osimertinib, with a progression-free survival of 5 months. | osimertinib | epidermal growth factor receptor | Homo sapiens |